Aesculus hippocastanum
Species
KNApSAcK Entry
| Organism name | Aesculus hippocastanum |
|---|---|
| Genus | Aesculus |
| Family | Sapindaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Aesculus hippocastanum |
|---|---|
| Linked NCBI taxonomy ID | 43364 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Hippocastanaceae |
|---|---|
| ID | 910346 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | rosids |
|---|---|
| ID | 71275 |
Metabolite list (34)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00005435
|
Quercetin 3,3'-diglucoside
|
No. 1 | No. 15 |
|
||||
|
C00005132
|
Juglanin
/ Kaempferol 3-O-arabinoside / (-)-Kaempferol 3-O-arabinoside |
CHEMBL469440
|
No. 2 | No. 15 |
|
|||
|
C00005386
|
Quercetin 3'-glucoside
/ 3,5,7,3',4'-Pentahydroxyflavone |
CHEMBL1222354
|
No. 2 | No. 15 |
|
|||
|
C00006062
|
Quercetin 3'-glucoside-7-acetate
|
No. 2 | No. 15 |
|
||||
|
C00004649
|
Quercetin 7,3',4'-trimethyl ether
/ 3,5-Dihydroxy-7,3',4'-trimethoxyflavone / 2-(3,4-Dimethoxyphenyl)-3,5-dihydroxy-7-methoxy-4H-1-benzopyran-4-one |
CHEMBL1689343
|
1 / 2 / 0 | No. 3 | No. 15 |
|
||
|
C00004642
|
Rhamnazin
/ 7,3'-Di-O-methylquercetin / 3,4',5-Trihydroxy-3',7-dimethoxyflavone / 3,5-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-4H-1-benzopyran-4-one |
CHEMBL457148
|
No. 3 | No. 15 |
|
|||
|
C00004773
|
Myricetin 7,3',4'-trimethyl ether
|
No. 3 | No. 15 |
|
||||
|
C00003497
|
Aescin
|
CHEMBL403501
CHEMBL405484 CHEMBL507233 CHEMBL505939 CHEMBL1159568 CHEMBL1875956 |
D004928
|
3 / 0 / 0 | No. 4 | No. 51 |
|
|
|
C00005476
|
Quercetin 3-sambubioside-3'-glucoside
|
CHEMBL474596
|
No. 5 | No. 15 |
|
|||
|
C00003505
|
Barringtogenol C
|
CHEMBL487606
|
No. 13 | No. 51 |
|
|||
|
C00009076
|
Procyanidin B5
/ Epicatechin-(4beta-6)-epicatechin |
CHEMBL506487
CHEMBL502984 CHEMBL451115 |
No. 16 | No. 19 |
|
|||
|
C00002935
|
Procyanidin B4
/ Catechin-(4alpha->8)-epicatechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
20 / 7 / 8 | No. 16 | No. 19 |
|
||
|
C00002934
|
Proanthocyanidin A2
/ Proanthocyanidin A-2 / (+)-Proanthocyanidin A-2 |
CHEMBL286933
CHEMBL81646 CHEMBL450916 |
C473740
|
13 / 3 / 4 | No. 16 | No. 19 |
|
|
|
C00009277
|
Proanthocyanidin A1
|
CHEMBL286933
CHEMBL81646 CHEMBL450916 |
13 / 3 / 4 | No. 16 | No. 19 |
|
||
|
C00009278
|
Proanthocyanidin A4
|
CHEMBL286933
CHEMBL81646 CHEMBL450916 |
13 / 3 / 4 | No. 16 | No. 19 |
|
||
|
C00009275
|
Proanthocyanidin A7
|
No. 16 | No. 19 |
|
||||
|
C00009075
|
Procyanidin B1
/ Epicatechin-(4beta->8)-catechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
C479579
|
20 / 7 / 8 | No. 16 | No. 19 |
|
|
|
C00009276
|
Proanthocyanidin A6
|
No. 16 | No. 19 |
|
||||
|
C00009077
|
Procyanidin B2
/ Epicathechin-(4beta->8)-epicathechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
C479580
|
20 / 7 / 8 | 10 / 0 | No. 16 | No. 19 |
|
|
C00009071
|
Procyanidin B3
/ Catechin-(4alpha->8)-catechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
20 / 7 / 8 | No. 16 | No. 19 |
|
||
|
C00009098
|
Procyanidin C1
/ [Epicatechin-(4beta->8)]2-epicatechin |
CHEMBL290632
|
13 / 5 / 6 | No. 29 | No. 19 |
|
||
|
C00009084
|
[Epicatechin-(4beta->6)]2-epicatechin
|
No. 29 | No. 19 |
|
||||
|
C00009300
|
Aesculitannin C
|
CHEMBL506298
|
No. 29 | No. 19 |
|
|||
|
C00009298
|
Epicatechin-(4alpha->8)-epicatechin-(2beta->7,4beta->8)-epicatechin
|
CHEMBL503368
|
No. 29 | No. 19 |
|
|||
|
C00009293
|
Aesculitannin B
|
CHEMBL540956
CHEMBL81478 CHEMBL445468 CHEMBL1213875 CHEMBL1213876 |
14 / 4 / 7 | No. 29 | No. 19 |
|
||
|
C00009292
|
Pavetannin B 1
|
CHEMBL540956
CHEMBL81478 CHEMBL445468 CHEMBL1213875 CHEMBL1213876 |
14 / 4 / 7 | No. 29 | No. 19 |
|
||
|
C00009291
|
Cinnamtannin B1
|
CHEMBL540956
CHEMBL81478 CHEMBL445468 CHEMBL1213875 CHEMBL1213876 |
14 / 4 / 7 | No. 29 | No. 19 |
|
||
|
C00009309
|
Aesculitannin G
|
No. 113 | No. 19 |
|
||||
|
C00009308
|
Cinnamtannin B2
|
CHEMBL410924
CHEMBL411351 CHEMBL502146 |
11 / 2 / 2 | No. 113 | No. 19 |
|
||
|
C00009304
|
Pavetannin C2
|
No. 113 | No. 19 |
|
||||
|
C00013284
|
Aesculitannin E
/ (+)-Aesculitannin E |
No. 113 | No. 19 |
|
||||
|
C00002474
|
Fraxin
|
CHEMBL293864
|
C080614
|
11 / 3 / 5 | No. 491 | No. 25 |
|
|
|
C00002472
|
Esculin
|
CHEMBL359043
CHEMBL482581 CHEMBL1434042 CHEMBL1515174 CHEMBL1536019 CHEMBL1619714 CHEMBL1624854 |
D004929
|
22 / 18 / 24 | 0 / 1 | No. 491 | No. 25 |
|
|
C00002473
|
Fraxetin
|
CHEMBL54909
|
C105671
|
32 / 21 / 23 | 6 / 0 | No. 864 | No. 25 |
|
Human Protein / Gene in interactions
66 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q04759 | Protein kinase C theta type | Delta | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 1 |
| Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| P41743 | Protein kinase C iota type | Iota | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| Q05655 | Protein kinase C delta type | Delta | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| P24723 | Protein kinase C eta type | Eta | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 1 / 0 |
| P05771 | Protein kinase C beta type | Alpha | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| O94806 | Serine/threonine-protein kinase D3 | Pkd | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| Q02156 | Protein kinase C epsilon type | Eta | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| P05129 | Protein kinase C gamma type | Alpha | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 1 / 1 |
| Q05513 | Protein kinase C zeta type | Iota | C00002934 C00002935 C00009071 C00009075 C00009077 C00009098 C00009277 C00009278 C00009291 C00009292 C00009293 C00009308 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002472 C00002473 C00002935 C00009071 C00009075 C00009077 | 3 / 3 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002472 C00002473 C00002935 C00009071 C00009075 C00009077 | 1 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002472 C00002473 C00002935 C00009071 C00009075 C00009077 | 0 / 1 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002472 C00002935 C00009071 C00009075 C00009077 | 1 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002473 C00002935 C00009071 C00009075 C00009077 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002472 C00002935 C00009071 C00009075 C00009077 | 0 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002472 C00002935 C00009071 C00009075 C00009077 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002472 C00009291 C00009292 C00009293 | 0 / 3 |
| P23467 | Receptor-type tyrosine-protein phosphatase beta | Receptor tyrosine-protein phosphatase | C00002935 C00009071 C00009075 C00009077 | 0 / 0 |
| P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00002935 C00009071 C00009075 C00009077 | 0 / 0 |
| P49763 | Placenta growth factor | Unclassified protein | C00002934 C00009277 C00009278 | 0 / 0 |
| P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00009291 C00009292 C00009293 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00002472 C00002473 C00002474 | 0 / 0 |
| P15692 | Vascular endothelial growth factor A | Secreted protein | C00002934 C00009277 C00009278 | 1 / 2 |
| Q06187 | Tyrosine-protein kinase BTK | Tec | C00009291 C00009292 C00009293 | 2 / 2 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002472 C00002473 | 1 / 2 |
| O00255 | Menin | Unclassified protein | C00002472 C00002473 | 2 / 5 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00002473 C00002474 | 0 / 0 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00002473 C00002474 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002472 C00002474 | 0 / 0 |
| P55210 | Caspase-7 | C14 | C00002472 C00002473 | 0 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00002473 C00002474 | 1 / 2 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00002473 C00002474 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00002473 C00002474 | 1 / 2 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00002473 C00002474 | 0 / 1 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002472 C00002473 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00002472 C00002473 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00002473 C00002474 | 1 / 1 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002472 C00002473 | 2 / 2 |
| Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002473 C00002474 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002472 C00002473 | 0 / 0 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002473 C00002474 | 0 / 0 |
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004649 | 2 / 0 |
| P08253 | 72 kDa type IV collagenase | M10A | C00009098 | 1 / 3 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002473 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00002473 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002473 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00002473 | 4 / 3 |
| P06280 | Alpha-galactosidase A | Enzyme | C00002472 | 1 / 1 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002472 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002473 | 1 / 1 |
| P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | C00002472 | 0 / 0 |
| P51684 | C-C chemokine receptor type 6 | CC chemokine receptor | C00003497 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002473 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00002473 | 0 / 0 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002472 | 0 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002473 | 0 / 0 |
| P32302 | C-X-C chemokine receptor type 5 | CXC chemokine receptor | C00003497 | 0 / 0 |
| P35414 | Apelin receptor | Neuropeptide receptor | C00003497 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00009098 | 2 / 2 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002472 | 1 / 1 |
| P04062 | Glucosylceramidase | Enzyme | C00002472 | 6 / 4 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002473 | 0 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00002473 | 4 / 1 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00002473 | 0 / 0 |
12 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002473
C00009077
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002473
C00009077
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002473
C00009077
|
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002473
C00009077
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00009077
|
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00002473
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00002473
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00009077
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00009077
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00009077
|
| 4240 | MFGE8, BA46, EDIL1, HMFG, HsT19888, MFG-E8, MFGM, OAcGD3S, SED1, SPAG10, hP47 | milk fat globule-EGF factor 8 protein |
C00009077
|
| 7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00009077
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (40)
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #300755 | Agammaglobulinemia, x-linked; xla |
Q06187
|
| #614490 | Blood group, junior system; jr |
Q9UNQ0
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #307200 | Isolated growth hormone deficiency, type iii; ighd3 |
Q06187
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #603933 | Microvascular complications of diabetes, susceptibility to, 1; mvcd1 |
P15692
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #601367 | Stroke, ischemic |
P24723
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
KEGG DISEASE (40)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
P15692 (marker) Q16790 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
| H00125 | Fabry disease |
P06280
(related)
|
| H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
| H00028 | Choriocarcinoma |
P08253
(related)
|
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00018 | Gastric cancer |
P15692
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00017 | Esophageal cancer |
P35354
(related)
|
| H00046 | Cholangiocarcinoma |
P35354
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00408 | Type I diabetes mellitus |
Q04759
(related)
|
| H00085 | Agammaglobulinemias |
Q06187
(related)
|
| H00254 | Pituitary Dwarfism (PD) |
Q06187
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|